help button home button Am J Pathol JNCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beniers, A. J.
Right arrow Articles by Schalken, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beniers, A. J.
Right arrow Articles by Schalken, J. A.

American Journal of Pathology, Vol 140, 483-495, Copyright © 1992 by American Society for Investigative Pathology


REGULAR ARTICLES

Establishment and characterization of five new human renal tumor xenografts

AJ Beniers, WP Peelen, HE Schaafsma, JL Beck, FC Ramaekers, FM Debruyne and JA Schalken
Department of Urology, University Hospital Nijmegen, The Netherlands.

Ten different human renal cell carcinoma (RCC) primary tumors were xenografted into BALB/c nu/nu mice. Five of the tumors (NU-10, NU-12, NU-20, NU-22, and NU-28) gave rise to serially transplantable tumors that were further characterized. Histology, DNA index, immunohistochemical characteristics, growth rate, and clonogenic potential were followed from primary tumor to the 5th to 15th transplant passage. Only one of the tumors (NU-20) showed remarkable instability for all tested parameters in the first five transplant passages. Histology of the other tumors was essentially the same to the histology of the primary tumors, although differences between human and host-derived vessels were apparent. DNA index values in general showed a trend toward an aneuploid character of the xenografts. Immunohistochemical analyses showed a loss of intensity of staining but a concomitant rise in the fraction of positively staining cells with antibodies against cytokeratins, vimentin, tumor-associated antigens, and human leukocyte antigen (HLA) class I antigens. Human leukocyte antigen class II antigen expression showed a loss of intensity as well as a decrease in the fraction of positive cells. Tumor doubling time was lowest in transplant passage number 0, and stable growth was noticed in transplant passages 1 through 4. Clonogenic potential of four of the lines was higher for the xenografts than for the primary tumors. The authors conclude that, on xenografting, histologic characteristics of the primary tumor are essentially conserved. Progression in the first transplant passages, however, results in tumors with a more aggressive character.


This article has been cited by other articles:


Home page
JNMHome page
F. G. van Schaijk, E. Oosterwijk, J. D. Molkenboer-Kuenen, A. C. Soede, B. J. McBride, D. M. Goldenberg, W. J.G. Oyen, F. H.M. Corstens, and O. C. Boerman
Pretargeting with Bispecific Anti-Renal Cell Carcinoma x Anti-DTPA(In) Antibody in 3 RCC Models
J. Nucl. Med., March 1, 2005; 46(3): 495 - 501.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
O. C. Boerman, M. H. G. C. Kranenborg, E. Oosterwijk, G. L. Griffiths, W. J. McBride, W. J. G. Oyen, M. de Weijert, J. Oosterwijk-Wakka, H. J. Hansen, and F. H. M. Corstens
Pretargeting of Renal Cell Carcinoma: Improved Tumor Targeting with a Bivalent Chelate
Cancer Res., September 1, 1999; 59(17): 4400 - 4405.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Society for Investigative Pathology.